Skip to main content

Peer Review reports

From: Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study

Original Submission
5 Feb 2021 Submitted Original manuscript
9 Apr 2021 Reviewed Reviewer Report
10 May 2021 Reviewed Reviewer Report
1 Aug 2021 Author responded Author comments - Yue Han
Resubmission - Version 2
1 Aug 2021 Submitted Manuscript version 2
3 Sep 2021 Author responded Author comments - Yue Han
Resubmission - Version 3
3 Sep 2021 Submitted Manuscript version 3
25 Sep 2021 Reviewed Reviewer Report
6 Oct 2021 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
7 Oct 2021 Editorially accepted
20 Oct 2021 Article published 10.1186/s12876-021-01967-3

You can find further information about peer review here.

Back to article page